Hub International Expands Life Sciences Practice to Address Evolving Risks
Event summary
- Hub International Limited expanded its Life Sciences Practice on May 14, 2026, to offer integrated risk advisory services across the U.S. and Canada.
- The practice targets organizations at all stages, from early-stage startups to commercialized multinationals.
- Services span business insurance, risk services, employee benefits, and retirement, addressing gaps traditional insurance cannot cover.
- Key risks addressed include clinical trial liability, funding volatility, and governance gaps.
The big picture
Hub International's expansion reflects the growing complexity of life sciences risks, including funding volatility and regulatory scrutiny. As traditional insurance programs fall short, integrated risk advisory services are becoming critical for organizations navigating clinical trials, product liability, and governance challenges. This move positions Hub to capitalize on the increasing demand for specialized risk management solutions in the life sciences sector.
What we're watching
- Market Differentiation
- Whether Hub's integrated approach can distinguish it from competitors in a crowded life sciences risk advisory space.
- Regulatory Scrutiny
- The pace at which regulatory frameworks evolve and how Hub adapts its services to meet new oversight requirements.
- Client Adoption
- How quickly life sciences organizations adopt Hub's stage-appropriate risk advisory services, particularly among early-stage startups.
Related topics
